Portal de Periódicos da CAPES

INVESTIGATING THE PHYSIOLOGICAL RELATIONSHIP BETWEEN ISCHEMIC HEART DISEASE AND HYPOTHYROIDISM

2022; Uttar Pradesh Zoological Society; Linguagem: Inglês

10.56557/upjoz/2022/v43i243308

0256-971X

Mohammed Salah Hussein, BAYAN MUJAHID M KABY, HAJAR YOUSIF ALYOUSIF, SALEM ALI AL MARRI, AHMAD ABDULAZIEM S. ALIBRAHIM, MALAK BASSAM ALRASHEED, ABDULAZIZ MOHAMMAD ALAIBAN, WADEEAH JAFAR ALMANASSIF, SHAHID ABDULLAH ALMAHDI, YAZEED FAHAD ALGHULAYQAH, MANAR ABDULWAHAB ALABDULSALAM, ABDULLAH MOHAMMED ALASSIRI, ABDULAZIZ ALI AL-THABET,

Thyroid Disorders and Treatments

Both hypothyroidism and hyperthyroidism, which are thyroid conditions that are extremely prevalent throughout the world, predispose to CVD in general and CAD in particular. This is especially important for people who have hypothyroidism. Heart failure progression risk and the frequency of coronary events are both raised by overt and subclinical hypothyroidism. Thyroid hormone abnormalities are a common complication of heart disease, especially ischemic heart disease, and should be taken into consideration. In actuality, it is necessary to consider low thyroid hormone levels as a cardiovascular risk factor. Regarding ischemic heart disease, thyroid hormones impact left ventricular structure, function, and geometry in the late post-myocardial infarction stage. Cardio-protection is the new goal of therapies to reduce infarct size and stop the development of heart failure following an acute ischemic event in order to enhance cardiovascular outcomes. Through TR1 binding, TH replacement therapy administered soon after myocardial infarction (or even when delayed) may enhance cardiac function. In this review we will look at the relationship between hypothyroidism and ischemic heart disease.